Matches in SemOpenAlex for { <https://semopenalex.org/work/W2484331370> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2484331370 abstract "Abstract Although paediatric acute lymphoblastic leukaemia (ALL) has a favourable prognosis, a number of cases will invariably relapse. One of the major problems associated with relapse is drug resistance, in particular to glucocorticoids, the mainstay of ALL treatment. Examining the underlying mechanisms is complicated by clonal heterogeneity within a patient and the potential impact of the leukaemic niche. To address mechanisms of drug resistance in a patient-relevant setting, we performed a genome-wide in vivo CRISPR screen in primary ALL material. To that end, we took advantage of primografted material from patient L707, who initially presented with a Dexamethasone (DEX) sensitive t(17;19) ALL, but relapsed 5 months after initial diagnosis. We transduced DEX sensitive presentation cells with the full genome GeCKOv2 CRISPR library, before transplantation into immunodeficient NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice. Mice were subsequently treated with DEX by oral gavage (15mg/kg for 5 weeks, 10mg/kg thereafter). DNA from several engrafted sites in the mouse was extracted and PCR amplified before being sequenced on the Illumina HiSeq2500. Changes in pool complexity were analysed using MaGEcK software to determine which sgRNAs were significantly enriched or depleted. By far the most significantly enriched sgRNAs were those targeting NR3C1, the gene encoding the glucocorticoid receptor. In addition, two of the top five significantly depleted sgRNAs targeted the Plexins, PLXNA1 and PLXND1. Whilst PLXNA1 is expressed at low levels, PLXND1 is highly expressed and has been linked to dexamethasone resistance. Notably, the matched relapsed material from L707 was highly DEX resistant both in tissue culture and when transplanted into NSG mice. SNP 6.0 analysis revealed a 5q deletion in the relapse, spanning 5 genes including NR3C1. Whole genome sequencing showed this was comprised of 2 deletions both targeting NR3C1, with different breakpoints for each allele. The differential gene expression between the L707 presentation and relapse established that NR3C1 was the most significant of all the genes lost at relapse, based on gene set enrichment analysis (GSEA). This contrasts with many ALL cases, where one of the downstream effectors of apoptosis is lost as opposed to NR3C1. Growth of the relapse material in vivo and in vitro was slower than the presentation in a competitive situation, but with DEX treatment the relapse phenotype began to emerge with a small percentage of cells showing a heterozygous deletion of NR3C1. These combined data strongly suggest that the NR3C1 deletion is the main driver of DEX resistance in the L707 relapse. Moreover, it proves that our in vivo CRISPR screen predicted the leukaemic relapse. These results confirm NR3C1 deletion as a driver in glucocorticoid resistance and demonstrate the power of in vivo CRISPR screens to predict mechanisms of gain of drug resistance and subsequent relapse. The parallels that can be drawn between the relapse and the CRISPR screen are striking, giving the indication that the progression from presentation to relapse may follow the same path in a patient derived xenograft setting as it did in the patient. Disclosures No relevant conflicts of interest to declare." @default.
- W2484331370 created "2016-08-23" @default.
- W2484331370 creator A5001639013 @default.
- W2484331370 creator A5001954889 @default.
- W2484331370 creator A5009384320 @default.
- W2484331370 creator A5024693074 @default.
- W2484331370 creator A5024966176 @default.
- W2484331370 creator A5034669735 @default.
- W2484331370 creator A5054358107 @default.
- W2484331370 creator A5082231595 @default.
- W2484331370 creator A5090417965 @default.
- W2484331370 creator A5037088318 @default.
- W2484331370 date "2015-12-03" @default.
- W2484331370 modified "2023-09-27" @default.
- W2484331370 title "A Whole Genome In Vivo Crispr Screen in Primary ALL Predicts Leukaemic Relapse" @default.
- W2484331370 doi "https://doi.org/10.1182/blood.v126.23.2619.2619" @default.
- W2484331370 hasPublicationYear "2015" @default.
- W2484331370 type Work @default.
- W2484331370 sameAs 2484331370 @default.
- W2484331370 citedByCount "0" @default.
- W2484331370 crossrefType "journal-article" @default.
- W2484331370 hasAuthorship W2484331370A5001639013 @default.
- W2484331370 hasAuthorship W2484331370A5001954889 @default.
- W2484331370 hasAuthorship W2484331370A5009384320 @default.
- W2484331370 hasAuthorship W2484331370A5024693074 @default.
- W2484331370 hasAuthorship W2484331370A5024966176 @default.
- W2484331370 hasAuthorship W2484331370A5034669735 @default.
- W2484331370 hasAuthorship W2484331370A5037088318 @default.
- W2484331370 hasAuthorship W2484331370A5054358107 @default.
- W2484331370 hasAuthorship W2484331370A5082231595 @default.
- W2484331370 hasAuthorship W2484331370A5090417965 @default.
- W2484331370 hasConcept C104317684 @default.
- W2484331370 hasConcept C134018914 @default.
- W2484331370 hasConcept C141231307 @default.
- W2484331370 hasConcept C203014093 @default.
- W2484331370 hasConcept C207001950 @default.
- W2484331370 hasConcept C2780401358 @default.
- W2484331370 hasConcept C502942594 @default.
- W2484331370 hasConcept C54355233 @default.
- W2484331370 hasConcept C71924100 @default.
- W2484331370 hasConcept C86803240 @default.
- W2484331370 hasConcept C98108389 @default.
- W2484331370 hasConceptScore W2484331370C104317684 @default.
- W2484331370 hasConceptScore W2484331370C134018914 @default.
- W2484331370 hasConceptScore W2484331370C141231307 @default.
- W2484331370 hasConceptScore W2484331370C203014093 @default.
- W2484331370 hasConceptScore W2484331370C207001950 @default.
- W2484331370 hasConceptScore W2484331370C2780401358 @default.
- W2484331370 hasConceptScore W2484331370C502942594 @default.
- W2484331370 hasConceptScore W2484331370C54355233 @default.
- W2484331370 hasConceptScore W2484331370C71924100 @default.
- W2484331370 hasConceptScore W2484331370C86803240 @default.
- W2484331370 hasConceptScore W2484331370C98108389 @default.
- W2484331370 hasLocation W24843313701 @default.
- W2484331370 hasOpenAccess W2484331370 @default.
- W2484331370 hasPrimaryLocation W24843313701 @default.
- W2484331370 hasRelatedWork W2281761662 @default.
- W2484331370 hasRelatedWork W2346169522 @default.
- W2484331370 hasRelatedWork W2518876197 @default.
- W2484331370 hasRelatedWork W2530649905 @default.
- W2484331370 hasRelatedWork W2548151239 @default.
- W2484331370 hasRelatedWork W2557312626 @default.
- W2484331370 hasRelatedWork W2558570689 @default.
- W2484331370 hasRelatedWork W2563952734 @default.
- W2484331370 hasRelatedWork W2565231530 @default.
- W2484331370 hasRelatedWork W2565565113 @default.
- W2484331370 hasRelatedWork W2572023093 @default.
- W2484331370 hasRelatedWork W2582318432 @default.
- W2484331370 hasRelatedWork W2582541527 @default.
- W2484331370 hasRelatedWork W2582883605 @default.
- W2484331370 hasRelatedWork W2585872289 @default.
- W2484331370 hasRelatedWork W2729176800 @default.
- W2484331370 hasRelatedWork W2968899969 @default.
- W2484331370 hasRelatedWork W2979577333 @default.
- W2484331370 hasRelatedWork W2979672845 @default.
- W2484331370 hasRelatedWork W2980403293 @default.
- W2484331370 isParatext "false" @default.
- W2484331370 isRetracted "false" @default.
- W2484331370 magId "2484331370" @default.
- W2484331370 workType "article" @default.